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The high-mobility group (HMG) proteins 14 and 17 are abundant chromosomal proteins that bind to nucleosomes and
enhance transcription. We report that both mRNA species and both proteins are present throughout oogenesis and
preimplantation development of the mouse. When antisense oligonucleotides targeting each mRNA species are injected
into one-cell embryos, the proteins become depleted at the two- and four-cell stages and reaccumulate at the eight-cell stage.
One-cell embryos injected with antisense oligonucleotides targeting both HMG-14 and HMG-17 cleave to the two-cell
stage. Subsequent cleavages, however, are delayed compared with control-injected embryos. Nevertheless, these embryos
ultimately reach the blastocyst stage. Similarly, injection into the nuclei of two-cell embryos of a peptide corresponding to
the common nucleosome-binding domain of HMG-14 and HMG-17 delays progression to the four-cell stage. Furthermore,
both RNA and protein synthesis is transiently reduced in antisense-injected embryos compared with injected controls.
These results identify HMG-14 and HMG-17 as constitutive components of mouse oocyte and embryonic chromatin and
establish a link between the structure of embryonic chromatin and the normal progression of embryonic
development. © 2001 Academic Press
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Chromatin of gametes and early embryos manifests
unique properties that distinguish it from chromatin of
other cell types. Transcription is active in growing oocytes,
becomes reduced to a very low level during meiotic matu-
ration and remains low following fertilization and is then
activated at a species-specific stage (reviewed by Telford et
al., 1990; Schultz, 1993; Nothias et al., 1995). Once embry-
onic transcription has been activated, flanking scaffold
attachment regions are able to increase transgene expres-
sion in response to histone hyperacetylation beginning at
the four-cell stage, but not at the two-cell stage in mice
(Thompson et al., 1995). Similarly, the ability of enhancer
sequences to stimulate promoter activity from injected
plasmids is developmentally regulated, these being active
in both proximal and distal locations beginning at the
two-cell stage, but only in proximal locations at the one-
cell stage (reviewed by Majumder et al., 1997; Kaneko and
0012-1606/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.DePamphilis, 1998; Lawinger et al., 1999). Oocytes and
embryos also display unusual DNA methylation patterns.
DNA becomes largely nonmethylated during oocyte devel-
opment and remains nonmethylated following fertilization
until after the blastocyst stage, when remethylation estab-
lishes the patterns found in adult tissue (Monk et al., 1987;
Sanford et al., 1987). Imprinted genes, however, retain
methylated sites in oocytes and early embryos (Olek and
Walter, 1997; Tremblay et al., 1997). Finally, nuclei of early
embryos are considered to be totipotent, based on their
ability to direct development of a new organism, whereas
nuclei of older embryos and adults may require exposure to
oocyte cytoplasm to gain this property.
To understand the molecular basis of these distinctive
properties, studies have been directed toward determining
the composition of embryonic chromatin. Somatic histone
H1 manifests changes in both quantity and subtype repre-
sentation during development of mouse oocytes and early
embryos (Clarke et al., 1992, 1998; Adenot et al., 2000;
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238 Mohamed, Bustin, and ClarkeStein et al., 2000). Acetylated isoforms of histone H4 are
differentially distributed in the early female and male
pronuclei (Adenot et al., 1997) and then become transiently
localized to the nuclear periphery at the two-cell stage
(Worrad et al., 1995; Stein et al., 1997). Histone acetylation
promotes the expression of both endogenous (Wiekowski et
al., 1993; Worrad et al., 1995; Davis et al., 1996) and
lasmid-borne (Wiekowski et al., 1991; Henery et al., 1995)
enes. The BRG1 and BRM genes of the mouse, which are
omologous to the yeast SWI2 gene, are expressed in
ocytes and newly fertilized embryos (LeGouy et al., 1998).
ubsequently, embryonic BRM becomes detectable only at
he blastocyst stage where it is restricted to the inner cell
ass (LeGouy et al., 1998). In contrast, BRG1 remains
resent throughout preimplantation development. Like
RG1, the high-mobility group (HMG) proteins HMG-I/Y
Thompson et al., 1995) and HMG-1 (Spada et al., 1998) are
lso present throughout preimplantation development, al-
hough HMG-1 becomes more abundant beyond the two-
ell stage. Recent results have implicated HMG-1 in the
nset of embryonic transcription (Beaujean et al., 2000).
Taken together, these studies have identified specific con-
stitutive and developmentally regulated elements of embry-
onic chromatin. Notwithstanding this progress, however,
our knowledge of embryonic chromatin composition re-
mains rather limited and the developmental role of the
chromosomal elements that have been identified is largely
unknown.
HMG-14 and HMG-17, which are structurally unrelated
to other HMG proteins, constitute a major family of chro-
mosomal proteins. They bind as homodimers to the nucleo-
some and are present in chromatin at approximately 10% of
the abundance of histones (reviewed by Bustin and Reeves,
1996). Several lines of evidence implicate HMG-14 and
HMG-17 in transcriptional regulation. Chromatin contain-
ing transcribable genes is two- to threefold enriched in
HMG-14 and HMG-17 compared with total chromatin
(Druckmann et al., 1986; Dorbic and Wittig, 1987; Postni-
kov et al., 1991). Antibodies against HMG-14 preferentially
stain transcriptionally active regions in polytene chromo-
somes of invertebrates (Westermann and Grossbach, 1984).
In cultured cells, HMG-14 and HMG-17 are concentrated in
foci that colocalize with RNA polymerase II and nascent
transcripts (Hock et al., 1998a), whereas they are undetect-
able in the nucleolus (Hock et al., 1998a). Introduction into
permeabilized cells of peptides corresponding to the
nucleosomal-binding domain of HMG-17 causes loss of
both HMG-17 nuclear staining and nonnucleolar transcrip-
tion (Hock et al., 1998a). Similarly, injection of anti-
HMG-17 antibodies into human fibroblasts causes a reduc-
tion in transcription (Einck and Bustin, 1983). Additionally,
experiments utilizing chromatin templates assembled in
either Xenopus oocyte (Crippa et al., 1993; Treischmann et
al., 1995) or Drosophila embryo (Paranjape et al., 1995)
extracts, as well as studies of SV40 minichromosomes
(Ding et al., 1994, 1997), all indicate that HMG-14 and
HMG-17 stimulate transcription. i
Copyright © 2001 by Academic Press. All rightIn Xenopus, studies in which sperm DNA was added to
egg extracts indicate that these eggs do not contain a supply
of HMG-14 and HMG-17 that is available for assembly into
chromatin (Crippa et al., 1992; Trieschmann et al., 1995a).
his result raised the possibility that HMG-14 and
MG-17 might be absent from early embryonic chromatin,
hich could underlie certain distinctive properties such as
ts transcriptional repression. To investigate this possibil-
ty, we examined the expression and function of HMG-14
nd HMG-17 in mouse oocytes and embryos. We found
hat, in contrast to Xenopus, HMG-14 and HMG-17 were
resent on mouse oocyte and early embryonic chromatin at
ll stages examined. Transient depletion or displacement of
hese proteins slowed the progression of preimplantation
evelopment and was associated with a transient reduction
n RNA and protein synthesis. These results establish a link
etween the structure of embryonic chromatin and the
ormal progression of embryonic development.
MATERIALS AND METHODS
Collection of Oocytes and Embryos
Oocytes arrested at prophase I of meiosis were obtained from
CD-1 female mice (Charles River Canada). Briefly, ovaries were
transferred to Hepes-buffered minimum essential medium
(MEM-H) supplemented with 50 mg/ml dibutyryl cyclic AMP
dbcAMP), and the ovarian follicles were punctured to release the
nclosed oocytes. Oocytes were incubated in bicarbonate-buffered
EM (GIBCO, Burlington, Ontario) containing 50 mg/ml dbcAMP
under oil at 37°C in 5% CO2 in air.
Embryos were obtained as described (Clarke et al., 1992). Briefly,
6D2F1 or CD-1 females (Charles River Canada) were superovu-
ated by an injection of 7.5 IU of pregnant mares’ serum gonado-
ropin (Sigma) followed 44–48 h later by 5 IU of human chorionic
onadotropin (hCG, Sigma) and caged individually with CD-1
ales overnight. One-cell embryos were obtained from mice killed
t day-0 (5 day of plug). In some cases, two-cell embryos were
ollected by flushing the oviducts of pregnant females on day-1.5.
hen older embryos were required, the 1- or two-cell embryos
ere cultured in KSOM medium under paraffin oil at 37°C in 5%
O2 in air until the desired stage.
Immunofluorescence
Embryos were freed of the zona pellucida by a 30-s exposure to
acidified (pH 2.5) Tyrode’s medium and incubated for 1 h at 37°C in
KSOM-H medium. Then they were fixed in freshly prepared 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at
room temperature, permeabilized in storage solution consisting of
PBS, 3% bovine serum albumin (BSA), 0.5% Triton X-100, and
either stored at 4°C or processed immediately for immunofluores-
cence staining. Before staining, embryos were incubated for 30 min
in blocking solution consisting of 900 ml storage solution, 100 ml
orse serum (GIBCO), 20 ml fish gelatin (1 mg/ml; Sigma). They
ere then transferred to a blocking solution containing affinity-
urified rabbit antibody against both HMG-14 and HMG-17, or
MG-14, or HMG-17 (Bustin, 1989; Bustin et al., 1990; Hock et al.,
998a,b) diluted 1:250 in blocking solution. Negative controls were
ncubated in the absence of primary antibody. Following overnight
s of reproduction in any form reserved.
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239HMG-14 and -17 During Early Mouse Embryogenesisincubation at 4°C with agitation, the embryos were washed three
times for 15 min each in blocking solution, then incubated for 1 h
at room temperature with agitation in the presence of a fluorescein
isothiocyanate-conjugated anti-rabbit antibody (Jackson Immu-
noresearch) diluted 1:100 in blocking buffer. The embryos were
then washed three times for 15 min each and mounted on a
microscope slide in a drop of Moviol (Hoechst, Montreal) contain-
ing 1,4-diazabicyclo[2.2.2]octane (25 mg/ml; Sigma) as an antifad-
ing agent and 1 mg/ml DAPI or propidium iodide to stain the DNA.
pecimens were examined using either a Leitz Laborlux S micro-
cope or a Zeiss confocal laser scanning microscope.
RNA Isolation
Oocytes or embryos (30 embryos per tube) were transferred into
a 0.5-ml microfuge tube containing 100 ml of lysing buffer (Trizol;
GIBCO). Ten micrograms of glycogen was added to the tubes,
which were mixed and allowed to stand for 5 min. In some
experiments, 3.0 pg of in vitro-transcribed RNA corresponding to
the vasa gene of Drosophila was added as a control for the
efficiency of RNA isolation. Twenty microliters of chloroform was
then added and the tubes were vigorously shaken, then allowed to
stand for 3 min. Following centrifugation for 10 min at 13,000 rpm,
the aqueous phase was transferred to a clean tube, to which was
added 100 ml of isopropanol. After a 10-min incubation at room
temperature, the tubes were centrifuged for 15 min at 13,000 rpm
and the supernatant was withdrawn. The RNA pellet was washed
with 70% ethanol, allowed to dry for 10–15 min, and dissolved in
10 ml of DEPC-treated water.
cDNA Synthesis
cDNA synthesis was carried out using standard procedures.
Briefly, each reaction mixture contained 10 ml of RNA solution, 27
nits of RNase inhibitor (Pharmacia), 2 ml of a dNTP mix of 10 mM
concentration, 4 ml of 53 reverse buffer (GIBCO), 2 ml of 10 mM
TT, 500 ng of oligo(dT)12–18 (Pharmacia) or 200 pmol of random
hexamers (Pharmacia), and 200 units of MMLV reverse transcrip-
tase (GIBCO). cDNA synthesis was allowed to proceed for 2–3 h at
37°C, after which the mixture was heated at 85°C for 10 min.
PCR Amplification
Primers were designed from the corresponding GenBank se-
quences: HMG-14, 59-ATGCCCAAGAGGAAGGTTAG and 39-
GAGACAGTCACAGCCTCTCC; HMG-17, 59-ACACTTCAT-
TACTGGGTGGG and 39-AGCCGACCCTGACTTTTAGG; vasa,
59-CTGGAGGTTATCGAGGAGGA and 39-TCGGCATCTTCG-
GCGATATT; and actin, 59-GTGGGCCGCTCTAGGCACCA and
39-TGGCCTTAGGGTGCAGGGGG.
Amplification was carried out using cDNA from 15 embryo
equivalents in a buffer consisting of 10 mM Tris (pH 8.3), 50 mM
KCl, 1.5 mM MgCl2, 200 mM dNTPs, 60–100 pmol of each primer,
and 2.5 units of Taq polymerase (various suppliers) in a total
volume of 50 ml. Each cycle consisted of 1 min at 94°C, 45 s at a
ene-specific temperature (58°C for HMG-14, 60°C for HMG-17,
0°C for vasa, 58°C for actin), and 45 s at 72°C. Forty cycles were
un for each experiment. To visualize the amplified products, 20 ml
of each PCR was electrophoresed through a 0.8–1.5% (w/v) agarose
gel containing 0.025% ethidium bromide. R
Copyright © 2001 by Academic Press. All rightMicroinjection of Oocytes and Embryos
Microinjection was carried out using a Leica inverted micro-
scope equipped with Leica micromanipulators (Leica Canada, Mon-
treal). The microinjection needle was pushed into the cytoplasm,
for oligonucleotide injection, or the nucleus, for peptide injection,
and using a PLI-100 microinjector (Medical Systems Corp., Green-
vale, NY) the solution was introduced by a pulse of positive
pressure supplied by compressed N2. It was possible to verify
isually that an embryo had been successfully microinjected by a
ispersal of cytoplasmic granules in the vicinity of the micropi-
ette tip or by slight nuclear swelling. Between injections, a
onstant positive pressure was maintained in the microinjection
eedle. Based on displacement during injection of the meniscus
arking the interface between solution and N2, it is estimated that
0 pl was injected into each cell (oocyte volume is about 250 pl).
ells were injected in groups of 10. Following microinjection, cells
ere incubated at 37°C in 5% CO2 in air. Embryos were inspected
t regular intervals to determine the stage of embryonic develop-
ent.
Oligonucleotides Used for Microinjection
Oligonucleotides (Sheldon Biotechnology Center, McGill Uni-
versity, Montreal) corresponding to HMG-14 and HMG-17 were 24
nt in length and spanned the protein synthesis initiation codon.
They were suspended in water at 0.8 mg/ml. The oligonucleotide
sequences were HMG-14 antisense, TAACCTTCCTCTTGGGC-
ATCGTGG; HMG-17 antisense, CAGCCTTTCTTTTGGGCAT-
GGTGG; and HMG-17 sense, CCACCATGCCCAAAAGAAAG-
GCTG.
Peptides Used for Microinjection
Peptides were prepared as described (Hock et al., 1998a). Peptide
2 (KDEPQRRSARLSAKPAPPKPEPKPKKAPAK) corresponds to the
nucleosomal binding region of HMG-17. The control peptide
(RAKPAKLPKAAPSPKADKERSRPKPQPKEP) has the same amino
acid composition as peptide 2, but in a scrambled sequence. Both
peptides were injected at a concentration of 10 mg/ml into both
uclei of two-cell stage embryos. Microinjection was carried out
8–40 h post-hCG injection to target S phase and G2 of the cell
ycle.
Quantification of RNA Synthesis
At the desired stage of labeling, embryos were permeabilized by
a 30-s incubation in 0.0065% lysolecithin (Sigma) (Khidir et al.,
1995), washed in 2 ml of warm KSOM-H, then cultured in KSOM
containing 1 mCi/ml [32P]UTP (Amersham; 3000 Ci/mmol). RNA
was extracted following the protocol of Clegg and Piko (1993). After
5 h of culture, embryos were washed five times in TBS-BSA (145
mM NaCl, 10 mM Tris–HCl, pH 7.6, 5 mg/ml BSA) and transferred
in ;5 ml of TBS-BSA to a microfuge tube containing 40 ml 0.5 N
erchloric acid. They were frozen and thawed six times in dry ice
nd ethanol, then centrifuged at 13,000 rpm for 15 min to precipi-
ate the RNA. For measurement of [32P]UTP uptake, the superna-
tant was transferred to a fresh tube, 20 ml of standardized KOH
olution (0.83 N KOH in 40 mM Tris–HCl, pH 8.3) was added, and
he tube was kept on ice for 5 min. Following centrifugation, the
adioactivity in the supernatant was counted using an LKB 1214
ackBeta liquid scintillation counter. For measurement of
s of reproduction in any form reserved.
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240 Mohamed, Bustin, and Clarke[32P]UTP incorporation into RNA, the precipitated RNA was hy-
rolyzed by adding 0.5 N NaOH, vortexed, and incubated at 37°C
or 1 h. At the end of the incubation period, the radioactivity was
easured as above. In preliminary experiments, we observed no
ifference in [32P]UTP incorporation whether the zona pellucida
as removed or not prior to incubation in the radioactive medium.
Quantification of Protein Synthesis
At the desired stage of labeling, embryos were cultured in KSOM
containing 100 mCi/ml L-[35S]methionine (Amersham; .1000 Ci/
mol). After 5 h of culture, embryos were washed twice, freed of
ona pellucida, and divided into two equal portions. For measure-
ent of radioactive methionine uptake, one portion was lysed in a
mall drop of 0.5% SDS. The lysate was then soaked into small
iece of filter paper (Whatman 3MM) and air-dried. For measure-
ent of radioactive methionine incorporation into the acid-
recipitable protein fraction, the other portion was lysed in a small
rop of 0.5% SDS, soaked into small piece of filter paper which was
hen immediately fixed in ice-cold 10% TCA, and then treated
ith 5% TCA at 95°C for 15 min. The paper was rinsed in ice-cold
CA and ethanol and air-dried. Radioactivity of the filter papers
as counted as described above.
RESULTS
Expression of HMG-14 and HMG-17 mRNAs and
Proteins in Oocytes and Embryos
To determine whether HMG-14 and HMG-17 were ex-
pressed in oocytes and preimplantation embryos, total RNA
was extracted from 30 oocytes or embryos at each stage.
Following reverse transcription, the cDNA was divided into
two equal parts, one of which was used to detect HMG-14
mRNA and the other to detect HMG-17 mRNA. Each was
subjected to PCR using the appropriate primers, and the
reaction products were visualized in 1.5% agarose gels
stained with ethidium bromide. Each oocyte and embryo
stage was analyzed in at least three separate trials.
As shown in Fig. 1, HMG-14 and HMG-17 mRNAs were
detected in oocytes and in embryos throughout preimplan-
tation development. There was a decline in the signal
intensity of both PCR products during early embryonic
development, with the weakest signal observed at the
two-cell stage. Both signals subsequently increased in de-
velopmentally more advanced embryos (Fig. 1). RT-PCR
analysis of embryos collected at different stages of the cell
cycle did not reveal any substantial changes in PCR product
during the cell cycle (data not shown). These results suggest
that, as is the case for many mRNA species (Bachvarova,
1985; Paynton et al., 1988), maternal mRNAs encoding
MG-14 and HMG-17 are present in oocytes and become
argely degraded by the two-cell stage, and embryonic
ranscripts accumulate beyond the two-cell stage.
To determine whether HMG-14 and HMG-17 proteins
ere present in oocytes and in preimplantation embryos,
hese were processed for immunofluorescence using
ffinity-purified antibodies recognizing either HMG-14 spe-
ifically, HMG-17 specifically, or both proteins (Hock et al.,
Copyright © 2001 by Academic Press. All right998a,b). All three antibodies produced the same staining
attern. Both HMG-14 and HMG-17 were present in the
uclei of growing and fully grown prophase I-arrested oo-
ytes (Fig. 2) and of embryos at all stages of preimplantation
evelopment (Fig. 3). Staining was present throughout the
uclei and was not restricted to the DAPI-stained regions
ontaining DNA. Staining was reduced, however, in the
ucleolus-like regions that did not stain for DNA. HMG-14
nd HMG-17 were not detectable in condensed chromo-
omes at meiotic (Fig. 2) or mitotic (not shown) metaphase.
his pattern of HMG-14 and HMG-17 distribution is simi-
ar to that recently described in cycling cells (Hock et al.,
998a,b) and indicates that, except for their possible dis-
lacement during M-phase, HMG-14 and HMG-17 are con-
titutive chromatin components in oocytes and preimplan-
ation embryos.
Effect of Injection of Antisense Oligonucleotides on
HMG-14 and HMG-17
To investigate the role of HMG-14 and HMG-17 during
the early embryonic cell cycles, we attempted to reduce
their cellular supply by microinjecting antisense oligonu-
cleotides. To test the effectiveness of the antisense oligo-
nucleotides, they were first injected into fully grown
FIG. 1. Detection by RT-PCR of mRNA encoding HMG-14 and
HMG-17 in oocytes and preimplantation embryos. RNA extracted
from 30 oocytes or embryos at each stage was reverse-transcribed
and subjected to PCR using appropriate primers. RNA encoding
Drosophila vasa protein was added as an exogenous control to
samples used for HMG-17 amplification. GV, oocyte arrested at
prophase I and containing a germinal vesicle; MII, oocyte at
metaphase II; 1c, 1-cell; 2c, 2-cell; 4c, 4-cell; 8c, 8-cell; BL, blasto-
cyst. Sizes of molecular weight markers in leftmost lane are
indicated.prophase I-arrested oocytes. These were incubated for 18 h
s of reproduction in any form reserved.
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241HMG-14 and -17 During Early Mouse Embryogenesisto allow meiotic maturation and then analyzed using RT-
PCR. As shown in Fig. 4, injection of antisense oligonucle-
otides substantially reduced the amount of PCR product
corresponding to HMG-14 mRNA or HMG-17 mRNA com-
pared with oocytes injected with the same quantity of sense
oligonucleotides or to uninjected oocytes (compare lane 5 to
lanes 1 and 3; lane 6 to lanes 2 and 4).
To test whether HMG-14 and HMG-17 proteins became
depleted in embryos following antisense oligonucleotide
FIG. 2. Detection by immunofluorescence of HMG-14 and HMG
an antibody recognizing both HMG-14 and HMG-17. The same stai
each pair, the left shows the DNA stained using DAPI; the right
distinguished by chromatin dispersed throughout the nucleus. (B
including a portion that surrounds the nucleolus-like body (Wickram
f nucleolus-like body. (C) Metaphase II. Oocyte chromosomes (le
mmunofluorescent.injection, one-cell embryos were injected at 25–27 h post- o
Copyright © 2001 by Academic Press. All rightCG and groups were fixed at the two-, four-, and eight-cell
tages. The fixed embryos were processed for immunofluo-
escence using either the anti-HMG-14 or the anti-HMG-17
ntibody. Only weak fluorescent signals for both proteins
ere observed in two- and four-cell embryos (Fig. 5). By the
ight-cell stage, however, the fluorescent signal had in-
reased to a level close to that of controls. These observa-
ions established that injection of antisense oligonucleo-
ides at the one-cell stage transiently depleted the quantity
roteins in oocytes. Oocytes were collected, fixed, and reacted with
pattern was observed using antibodies specific for each protein. For
s antibody staining in the same specimen. (A) Growing oocyte,
lly grown oocyte, distinguished by more condensed chromatin,
ghe et al., 1991; Debey et al., 1993). Note relatively weak staining
re unstained, whereas nuclei of attached somatic cells (right) are-17 p
ning
show
) Fu
asin
ft) af nuclear HMG-14 and HMG-17 in early embryos.
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightPreimplantation Development of Embryos Injected
with Antisense Oligonucleotides
To examine whether transient depletion of HMG-14 and
HMG-17 affected early embryonic development, one-cell
embryos were collected and injected at 25–27 h post-hCG
either with both HMG-14 and HMG-17 antisense oligonu-
cleotides or with an HMG-17 sense oligonucleotide. Each
embryo received the same total quantity (approximately 10
pg) of oligonucleotide. Eighty percent of each group cleaved
to the two-cell stage during overnight culture. The cleaved
embryos were selected for further culture and examined at
specific times after injection. Up to the eight-cell stage, the
number of cells in each embryo was recorded. During the
eight-cell stage, embryos undergo compaction after which
cell numbers cannot be determined in living embryos.
Consequently, beyond the eight-cell stage, we recorded
whether embryos had undergone compaction and blasto-
cyst formation. Thus, developmental progression was as-
sessed initially by cell number and later by embryonic
phenotype. In each experiment, one portion of the embryos
was injected with antisense oligonucleotides and the other
portion with sense oligonucleotides, and the subsequent
development of these was monitored in parallel.
We observed that the antisense-injected embryos consis-
tently developed more slowly than the sense-injected em-
bryos. By 62 h post-hCG, only 25% of antisense-injected
embryos had reached the four-cell stage, compared with
63% of the sense-injected embryos (Table 1, Fig. 6). By 76 h,
the delay was even more pronounced, as the fraction of
FIG. 4. Depletion by injected antisense oligonucleotides of
mRNAs encoding HMG-14 and HMG-17. Oligonucleotides were
injected into oocytes. Following overnight incubation, RNA was
extracted, reverse-transcribed, and subjected to PCR using the
indicated primers. HMG-14 was coamplified with actin; HMG-17
was coamplified with Drosophila vasa RNA added prior to RNA
extraction. Each lane represents 15 oocyte equivalents. Lane 1:
uninjected oocytes, HMG-14 and actin primers. Lane 2: uninjected
oocytes, HMG-17 and vasa primers. Lane 3: sense-injected oocytes,
HMG-14 and actin primers. Lane 4: sense-injected oocytes,
HMG-17 and vasa primers. Lane 5: antisense-injected oocytes,
HMG-14 and actin primers. Lane 6: antisense-injected oocytes,
HMG-17 and vasa primers. Leftmost lane is 100 bp ladder; 600-bpFIG. 3. Detection by immunofluorescence of HMG-14 and
HMG-17 proteins in preimplantation embryos. Embryos were
collected, fixed, and reacted with an antibody recognizing both
HMG-14 and HMG-17. The same staining pattern was observed
using antibodies specific for each protein. For each pair, the left
shows the DNA stained using DAPI; the right shows antibody
staining in the same specimen. (A) One-cell embryo. HMG-
14/-17 are localized in male and female pronuclei, but reduced in
nucleolar-like regions. Second polar body (right) is weakly
stained. (B) Two-cell embryo. HMG-14/-17 are localized in both
nuclei. Areas of weak staining represent nucleolar-like regions.
(C) Four-cell embryo. All nuclei, as well as polar body (bottom,
middle) are stained. (D) Late morula. All nuclei are stained.
Apparent increased signal in center of nuclei is a stainingfragment is identified.
s of reproduction in any form reserved.
243HMG-14 and -17 During Early Mouse EmbryogenesisFIG. 5. Transient depletion by injected antisense oligonucleotides of HMG-14 and HMG-17 proteins. Each oligonucleotide was injected
into 1-cell embryos, which were incubated until the 2-, 4-, or 8-cell stage and then fixed and processed for immunofluorescence using an
anti-HMG-14 antibody (A) or an anti-HMG-17 antibody (B). Top shows sense- or nonsense-injected embryos; bottom shows antisense-
injected embryos. Antisense-injected embryos display reduced fluorescent signal at the 2- and 4-cell stages, but approximately normal
signal at the 8-cell stage.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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244 Mohamed, Bustin, and Clarkeantisense-injected embryos at the 8-cell stage was only
one-third that of controls. This difference was maintained
at the early morula stage (84 h, 20% vs 58%). By 96 h,
however, approximately the same fraction of each group
were morulae, and by 120 h post-hCG most antisense- and
sense-injected embryos had formed blastocysts. The same
TABLE 1
Preimplantation Development of Embryos Injected at the One-Cel
HMG-14 and HMG-17
Time examineda No. embryos 2-cell
Sense-inje
62 h 84 37
76 h 84 10
84 h 84 7
96 h 84 7
120 h 84c 6
Antisense-in
62 h 127 75
76 h 127 24
84 h 127 20
96 h 127 16
120 h 122d 12
a Hours post-hCG.
b Cumulative results of four experiments.
c Two dead embryos at 120 h.
d Five embryos lost at 120 h.
* Significantly different from sense-injected (x2, P , 0.02).
** Significantly different from sense-injected (x2, P , 0.05).
FIG. 6. Development of embryos injected with antisense or se
overnight culture those that cleaved to the 2-cell stage were select
for the number of cells or, following compaction, for development t
had reached the specified stage at the specified time. Results are
White bars: HMG-17 sense sequence injected. Black bars: antisens
of antisense- and sense-injected embryos differs significantly at each ti
Copyright © 2001 by Academic Press. All rightevelopmental delay was also observed in one-cell embryos
njected with antisense phosphothiorate-linked oligonucle-
tides, but was not observed in embryos injected with
ntisense oligonucleotides targeting either HMG-14 or
MG-17 alone or with nonsense oligonucleotides (data not
hown). These results establish that depletion of both
ge with Sense or Antisense Oligonucleotides Targeting
Percentage of embryos at indicated stage
cell 5- to 8-cell Morula Blastocyst
embryosb
3
2 40 8
4 20 58
5 6 76 6
7 2 12 68
d embryosb
5*
9 14* 2
5 24 20*
3 5 63* 4
7 5 23 53**
ligonucleotides. One-cell embryos were injected, and following
r further culture. At each time indicated, the embryos were scored
morula or blastocyst stage. Shown is the fraction of embryos that
from Table 3 and are the sum of four independent experiments.
uences targeting HMG-14 and HMG-17 co-injected. Developmentl Sta
4-
cted
6
4
1
jecte
2
5
3
1nse o
ed fo
o the
taken
e seqme point (x2, P , 0.05).
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sion through the early cleavage divisions. The embryos
ultimately reached the blastocyst stage, however, indicat-
ing that the depletion of HMG-14 and HMG-17 did not
cause developmental arrest or lethality. Thus, transient
depletion of HMG-14 and HMG-17 was associated with a
delay in embryonic development.
Preimplantation Development of Embryos Injected
with Peptides
The results described above implied that HMG-14 and
HMG-17 were required to maintain the normal timing of
early embryonic development. To test this idea, we em-
ployed a second strategy to inhibit the activity of HMG-14
and HMG-17. Injection of a peptide corresponding to the
common nucleosome-binding domain of HMG-14 and
HMG-17 displaces these proteins from chromatin in vitro
(Trieschmann et al., 1995b) and reduces transcription in
permeabilized cells (Hock et al., 1998a). We tested whether
injection of these peptides could delay embryonic develop-
ment. As the first cell cycle does not require embryonic
transcription and therefore might not be sensitive to inhi-
bition of HMG-14 and HMG-17 activity, two-cell embryos
were collected and the nucleus of each blastomere was
injected either with the peptide containing the nucleosome-
binding domain or with a control peptide containing the
same amino acids in a scrambled sequence. For each em-
bryo, both nuclei were injected with the same peptide.
Injected embryos were examined at regular intervals and
the number of blastomeres that had undergone cleavage at
each time point was recorded.
Figure 7 shows the combined results of three independent
trials. In each trial, cleavage from the two- to four-cell stage
FIG. 7. Time of cleavage of blastomeres injected with scrambled
embryos were injected. At each time indicated, embryos were exam
recorded. Results are the sums of three independent experiments
peptide injected. Cleavage of scrambled- and sense-injected embrywas significantly delayed in blastomeres injected with the
Copyright © 2001 by Academic Press. All rightsense peptide compared to those injected with the
scrambled peptide. Subsequent cleavages were not moni-
tored owing to the unknown stability of the peptides within
the cytoplasm. Thus, microinjection of peptides that dis-
place HMG-14 and HMG-17 from chromatin was associ-
ated with a delay, but not arrest, of developmental progres-
sion.
RNA and Protein Synthesis in Embryos Depleted of
HMG-14 and HMG-17
To investigate the possible molecular basis of the delayed
embryonic development, we examined whether, as is the
case in cultured somatic cells (Hock et al., 1998a), depletion
of HMG-14 and HMG-17 from embryonic cells reduced
their transcriptional activity. One-cell embryos were col-
lected and separated into two groups, one of which was
injected (25–27 h post-hCG) with both HMG-14 and
HMG-17 antisense oligonucleotides and the other with
HMG-17 sense oligonucleotide. Each embryo received the
same total quantity (approximately 10 pg) of oligonucleo-
tide. Following incubation for specific periods of time,
embryos that had reached the two-, four-, or eight-cell stage,
as appropriate, were then vitally permeabilized using lyso-
lecithin as described (Khidir et al., 1995) and incubated in
medium containing [32P]UTP for 5 h. RNA was extracted
and the incorporated radioactivity was measured as de-
scribed (Clegg and Piko, 1993). When the label was added at
the late two-cell stage, no difference in the quantity incor-
porated into RNA was detectable between sense- and
antisense-injected embryos (Table 2). When the label was
added at the four-cell stage, however, the antisense-injected
embryos incorporated substantially less radioactivity into
RNA than did the sense-injected embryos. At the eight-cell
uence or sense peptides. The nuclei of both blastomeres of 2-cell
and the number of blastomeres that had undergone cleavage was
ite bars: scrambled-sequence peptide injected. Black bars: sense
ffers significantly at 51, 53, and 56 h (x2, P , 0.05).-seq
ined
. Whstage, the antisense-injected embryos also showed reduced
s of reproduction in any form reserved.
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246 Mohamed, Bustin, and Clarkeincorporation of label compared to sense controls, although
the difference was less than at the four-cell stage. Thus,
transient depletion of HMG-14 and HMG-17 was associated
with a corresponding decrease in total RNA synthesis.
To test whether the reduction in RNA synthesis was
accompanied by a reduction in total protein synthesis,
one-cell embryos were injected with antisense or sense
oligonucleotides and incubated for specific periods of time
as described above. Embryos that had reached the two-,
four-, or eight-cell stage were then incubated in medium
containing [35S]Met for 5 h, and incorporation of acid-
precipitable radioactivity was determined. At the two- and
four-cell stages, incorporation was reduced by about 30% in
the antisense-injected embryos compared to the sense-
injected embryos (Table 3). By the eight-cell stage, however,
the two groups incorporated similar amounts of label.
[Incorporation of label by embryos at different stages cannot
easily be compared as the endogenous methionine pool
becomes larger in more advanced embryos (Schultz et al.,
1981).] Thus, protein synthesis in the antisense-injected
embryos was reduced at the same stages when the amount
of HMG-14 and HMG-17 in chromatin was reduced and
returned to control levels at the stage when HMG-14 and
HMG-17 reappeared on chromatin.
DISCUSSION
We have investigated the expression and function of the
chromatin-associated proteins HMG-14 and HMG-17 dur-
ing early embryonic development of the mouse. Both the
encoding mRNAs and the proteins were detected at all
stages of oogenesis and preimplantation embryogenesis
examined. Previous studies have identified both constitu-
tive and developmentally regulated elements of early em-
bryonic chromatin. These results have led to the proposal
TABLE 2
Incorporation of [32P]UTP by Embryos Injected at the One-Cell
tage with Sense or Antisense Oligonucleotides Targeting
MG-14 and HMG-17
Stage when
labeled Expt
Incorporation 3
102/uptake
Antisense/
senseSense Antisense
2-cell 1 5.19 4.21 0.81
2 6.99 7.68 1.10
3 3.30 3.95 1.20
4-cell 1 14.28 5.35 0.38
2 8.07 3.32 0.41
3 10.23 3.62 0.35
4 5.39 2.43 0.45
8-cell 1 9.24 7.17 0.77
2 5.60 2.89 0.52that embryonic chromatin may undergo a sequence of
Copyright © 2001 by Academic Press. All rightrogrammed modifications, collectively termed matura-
ion, during the early embryonic cell cycles (Thompson et
l., 1995, 1998). Our results indicate that this maturation
rocess does not include major changes in the quantity of
hromosomal HMG-14 and HMG-17. Rather, HMG-14 and
MG-17 are constitutive components of mouse oocyte and
mbryonic chromatin.
The rapid depletion of HMG-14 and HMG-17 proteins
hat occurred following injection of antisense oligonucleo-
ides implies that, as in Xenopus, the early mouse embryo
oes not inherit a substantial maternal supply of these
roteins. The protein assembled onto embryonic nuclei is
herefore likely the product of embryonic gene activity.
onsistent with this, we observed a decrease in PCR
roduct at the two-cell stage followed by an increase at the
our-cell stage, reflecting loss of maternal mRNA followed
y accumulation of embryonic mRNA. The depletion of the
xisting HMG-14 and HMG-17 protein in antisense-
njected embryos may be attributed to the combined effect
f two processes. First, catabolism of the existing protein
ikely diminishes the supply of HMG-14 and HMG-17.
lthough the stability of cellular HMG-14 and HMG-17 is
ot known, the average half-life of proteins of the early
ouse embryo is about 12 h (Merz et al., 1981). Second, the
emaining HMG-14 and HMG-17 likely become appor-
ioned between existing and newly synthesized chromatin,
urther reducing the quantity per nucleus. Similarly, the
eaccumulation of HMG-14 and HMG-17 at the eight-cell
tage likely results from the time-dependent loss of the
ntisense oligonucleotide introduced at the one-cell stage
ogether with continuing synthesis of new encoding
RNAs by the developing embryo. Previous workers have
lso noted a transient effect of antisense oligonucleotides
ntroduced into mouse embryos (Jones et al., 1997).
Depletion of HMG-14 and HMG-17 was associated with
delay in embryonic development that was detectable as
arly as the cleavage from two to four cells. Injection of
eptides that displace HMG-14 and HMG-17 from nucleo-
omes also delayed this cleavage division. Subsequently,
he HMG-depleted embryos continued to develop more
TABLE 3
Incorporation of [35S]Met by Embryos Injected at the One-Cell
tage with Sense or Antisense Oligonucleotides Targeting
MG-14 and HMG-17
Stage when
labeled Expt
Incorporation 3102/uptake
Antisense/
senseSense Antisense Puromycin
2-cell 1 5.3 3.5 0.35 0.66
2 5.6 3.8 0.45 0.68
4-cell 1 5.7 3.9 0.36 0.68
2 5.4 4.2 1.0 0.78
8-cell 1 3.2 3.3 0.42 1.03
2 3.7 3.8 0.47 1.03
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247HMG-14 and -17 During Early Mouse Embryogenesisslowly than controls. Importantly, however, these embryos
ultimately reached the blastocyst stage at the same fre-
quency as controls. This indicates that, in the transient
absence of HMG-14 and HMG-17 from chromatin, embry-
onic development was not arrested but rather progressed
more slowly. These results imply that a normal quantity of
HMG-14 and HMG-17 is required to maintain the normal
timing of the early embryonic cell cycles.
Embryos from which HMG-14 and HMG-17 had been
depleted also manifested a reduced rate of RNA synthesis
compared to controls. In normal embryos, RNA synthesis
increases as preimplantation development progresses, al-
though it remains approximately constant on a per-cell
basis (Schultz, 1986). As the HMG-depleted embryos devel-
oped more slowly than controls, it could be proposed that
their decreased RNA synthesis was not a direct result of
depletion of HMG-14 and HMG-17, but rather was an
indirect result of their developmental delay. However, in
these experiments, we collected only those antisense-
injected embryos that had reached the same cleavage stage
(i.e., 2, 4, or 8 cells) as the sense-injected embryos. This
procedure meant that in fact RNA synthesis was measured
in the fastest developing antisense-injected embryos and so
may have underestimated the effect of HMG depletion.
It should be noted nonetheless that there was a delay
between the detectable depletion of HMG-14 and HMG-17,
at the two-cell stage, and the detectable reduction in RNA
synthesis, at the four-cell stage. In somatic cells, HMG-14
and HMG-17 selectively enhance RNA polymerase II-
dependent transcription (Hock et al., 1998a). In the mouse
mbryo, less than 10% of the total RNA synthesis and
ontent is accounted for by mRNA, most of the remainder
eing rRNA (Piko and Clegg, 1982; Clegg and Piko,
983a,b). Hence, only a small fraction of the RNA synthesis
f early embryos is RNA polymerase II-dependent. A reduc-
ion in synthesis of this class of RNA probably would not
mmediately affect the measured rate of total RNA synthe-
is. Thus, it may be that inhibition of the quantitatively
inor polymerase II-dependent transcription at the two-
ell stage led to a subsequent decrease in quantitatively
ajor polymerase I-dependent transcription at the four-cell
tage. We propose that, as they do in cultured somatic cells
Hock et al., 1998a), HMG-14 and HMG-17 serve an impor-
ant role in maintaining the normal rate of RNA synthesis
n early mouse embryos.
Depletion of HMG-14 and HMG-17 also was associated
ith a reduction in the rate of protein synthesis at the
wo-cell stage. Protein synthesis remained depressed at the
our-cell stage but, by the eight-cell stage when both
MG-14 and HMG-17 could be newly detected in the
lastomere nuclei, it had returned to normal levels. Thus,
here was a close temporal correlation between depletion of
MG-14 and HMG-17 and reduction in protein synthesis.
s much of the maternally inherited mRNA is destroyed by
he two-cell stage in mice (Bachvarova, 1985; Piko and
legg, 1982), it is reasonable to infer that the rate of
mbryonic protein synthesis depends largely on the quan-
Copyright © 2001 by Academic Press. All rightity of mRNA synthesized by the embryo. Therefore it may
e supposed that the reduction in protein synthesis in the
MG-depleted embryos is a result of decreased polymerase
I-dependent transcription.
It is tempting to speculate that the reduced rate of protein
ynthesis in HMG-depleted embryos underlies their devel-
pmental delay. In support of this notion, partial inhibition
f protein synthesis delays the embryonic cleavage cycles in
he sea urchin (Yamada, 1998). In the mouse, little is known
f the factors that determine the length of the early embry-
nic cell cycles (Bolton et al., 1984; Howlett and Bolton,
985; Smith and Johnson, 1986; Moore et al., 1996). Mam-
alian embryos express the same cyclin and cyclin-
ependent kinase family members (Moore et al., 1996) that
enerally drive the eukaryotic cell cycle (reviewed by Nigg,
995; Dynlacht, 1997), but their function in determining
mbryonic cell cycle progression has not been formally
emonstrated and the mechanisms that govern the timing
f their expression have not been identified. HMG-14 and
MG-17 could directly enhance transcription of cyclins or
ther cell-cycle regulatory genes or could act indirectly by
nhancing transcription of genes whose products regulate
asal cell metabolism. Identification of specific genes regu-
ated by HMG-14 and HMG-17 will provide further insight
nto the link established in this report between the struc-
ure of embryonic chromatin and the progression of embry-
nic development.
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